Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs?
Publication
, Journal Article
Black-Maier, E; Piccini, JP
Published in: Heart
June 2017
Duke Scholars
Published In
Heart
DOI
EISSN
1468-201X
Publication Date
June 2017
Volume
103
Issue
11
Start / End Page
807 / 808
Location
England
Related Subject Headings
- Thrombolytic Therapy
- Stroke
- Kidney Failure, Chronic
- Humans
- Cardiovascular System & Hematology
- Blood Coagulation
- Atrial Fibrillation
- Anticoagulants
- Administration, Oral
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Black-Maier, E., & Piccini, J. P. (2017). Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs? Heart, 103(11), 807–808. https://doi.org/10.1136/heartjnl-2016-310540
Black-Maier, Eric, and Jonathan P. Piccini. “Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs?” Heart 103, no. 11 (June 2017): 807–8. https://doi.org/10.1136/heartjnl-2016-310540.
Black-Maier E, Piccini JP. Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs? Heart. 2017 Jun;103(11):807–8.
Black-Maier, Eric, and Jonathan P. Piccini. “Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs?” Heart, vol. 103, no. 11, June 2017, pp. 807–08. Pubmed, doi:10.1136/heartjnl-2016-310540.
Black-Maier E, Piccini JP. Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs? Heart. 2017 Jun;103(11):807–808.
Published In
Heart
DOI
EISSN
1468-201X
Publication Date
June 2017
Volume
103
Issue
11
Start / End Page
807 / 808
Location
England
Related Subject Headings
- Thrombolytic Therapy
- Stroke
- Kidney Failure, Chronic
- Humans
- Cardiovascular System & Hematology
- Blood Coagulation
- Atrial Fibrillation
- Anticoagulants
- Administration, Oral
- 3202 Clinical sciences